Filter
1418
Filtered Results: 1418
Text search:
adverse
drug
event
Featured
Recommendations
181
New Publications
349
Language
Document type
No document type
794
Guidelines
277
Studies & Reports
171
Manuals
87
Strategic & Response Plan
42
Fact sheets
20
Training Material
14
Situation Updates
6
Infographics
3
Brochures
1
App
1
Resource Platforms
1
Online Courses
1
Countries / Regions
India
94
Global
43
Western and Central Europe
40
South Africa
34
Ethiopia
30
Kenya
29
Nigeria
24
Latin America and the Carribbean
23
Ghana
22
Bangladesh
18
Uganda
18
Eastern Europe
18
Nepal
15
Africa
15
Tanzania
15
Sierra Leone
12
Philippines
12
South–East Asia Region
12
Liberia
11
Myanmar / Burma
11
Rwanda
9
Zimbabwe
9
Cambodia
9
Namibia
9
Zambia
9
Malawi
8
USA
8
Colombia
7
Asia
7
Eastern Europe and Central Asia
7
Syria
6
Argentina
6
Brazil
6
Ukraine
5
Western Pacific Region
5
East and Southern Africa
5
Botswana
5
Indonesia
5
Mozambique
4
West and Central Africa
4
Eswatini/ Swaziland
4
Timor Leste/ East Timor
3
Thailand
3
Lesotho
3
Germany
3
Middle East and North Africa
3
South Sudan
3
North Macedonia
2
Tajikistan
2
China
2
Chile
2
Laos
2
Congo, Democratic Republic of
2
Paraguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Georgia
2
Angola
2
Bhutan
2
North Korea
1
Australia
1
Kazakhstan
1
Cameroon
1
Albania
1
Fiji
1
Kyrgyzstan
1
Bulgaria
1
Guinea
1
Haiti
1
Guinea-Bissau
1
Ireland
1
North America
1
Belarus
1
Lebanon
1
Sri Lanka
1
Russia
1
Iraq
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
447
Clinical Guidelines
230
Public Health
93
Women & Child Health
73
Key Resources
46
Pharmacy & Technologies
24
Capacity Building
21
Toolboxes
TB
154
Mental Health
144
HIV
132
COVID-19
80
Pharmacy
73
NTDs
59
AMR
57
Rapid Response
39
NCDs
32
Caregiver
31
Ebola & Marburg
23
Planetary Health
20
Refugee
18
Global Health Education
16
Specific Hazards
14
Conflict
13
Polio
11
Disability
9
Cholera
7
Natural Hazards
6
Zika
4
Health Financing Toolbox
3
Social Ethics
2
Malaria
2
This guide has been written for managers of national and district trachoma control programmes. It sets out, step-by-step, what is needed to assess the magnitude and extent of the trachoma problem in the area and how to plan, implement, monitor and evaluate a programme to control, and ultimately elim...
Anxiety disorders
Chapter F.2
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interesting both for health-care professionals and policy-...
The new WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
Externalizing disorders
Chapter 1.1
Antimicrobial resistance (AMR) is a serious public health concern with economic, social and political implications that are global in scope, and cross all environmental and ethnic boundaries. As a global threat, AMR risks the achievements of modern medicine, and has the po...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
SCOPING QUESTION: In adults with acute convulsive seizures, where intravenous access is available, which first-line anti- epileptic medication should be used to abort seizures when compared to comparator?
SCOPING QUESTION: For adults and children with medication-resistant convulsive epilepsy, which anti-epileptic medications produce benefits and/or harm in the specified outcomes when compared to a placebo or a comparator?
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV‑2) causing coronavirus disease 2019 (COVID-19) has reached pandemic levels;
Patients with cardiovascular (CV) risk factors and established cardiovascular disease (CVD) represent a vulnerable population when suffering from COVID-19;
Patien...
NSW Disaster Mental Health Handbook 1
The Disaster Mental Health Manual and associated handbooks are intended as a resource for mental health staff who are seeking background information and practical guidance and resources to assist in a disaster mental health response.
This module introduces the “Vaccinator’s Manual”, a guideline for vaccinators. The aim of the manual is to update EPI guidelines to include all the changes since the third edition of the Vaccinators Manual (2008)
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
2nd edition
Chapter 10 of Pediatric Surgery: This chapter provides an overview of some of the challenges when providing anaesthesia care for children in Africa. The chapter reviews
the cardiac, respiratory, and renal differences of children in comparison to adults. Additionally, it addresses preoperative asses...
